Frontier Biotechnologies Inc (688221)

Currency in CNY
21.53
+0.06(+0.28%)
Closed·
688221 Scorecard
Full Analysis
Net income is expected to grow this year
688221 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.9823.30
52 wk Range
4.4824.67
Key Statistics
Bid/Ask
21.52 / 21.53
Prev. Close
21.47
Open
21.5
Day's Range
20.98-23.3
52 wk Range
4.48-24.67
Volume
32.18M
Average Volume (3m)
16.22M
1-Year Change
298.7%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688221 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Frontier Biotechnologies Inc Company Profile

Frontier Biotechnologies Inc., a commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patient health in China. The company’s medicines address the unmet medical needs of patients in the areas of anti-HIV treatment and pain management. It offers Aikening, a long-acting HIV fusion inhibitor for the treatment of HIV infection and AIDS. The company’s products in development include small RNA drugs, such as FB7011/FB7013/FB7014 to treat IgA nephropathy, FB7022/FB7021 for dyslipidemia, and FB7012/FB7041/FB7031/FB7032 for various other diseases, including hyperuricemia and gout, tumors, and metabolic-associated fatty liver diseases; FB4001, to treat patients with osteoporosis or high risk of fracture; and FB3002, for the treatment of pain in muscles, bones, and joints. Frontier Biotechnologies Inc. was founded in 2002 and is headquartered in Nanjing, China.

Employees
302
Market
China

Compare 688221 to Peers and Sector

Metrics to compare
688221
Peers
Sector
Relationship
P/E Ratio
−42.5x−19.8x−0.5x
PEG Ratio
−1.100.750.00
Price/Book
7.4x6.8x2.6x
Price / LTM Sales
60.6x20.9x3.3x
Upside (Analyst Target)
-0.3%45.4%
Fair Value Upside
Unlock−15.6%7.7%Unlock

Earnings

Latest Release
May 05, 2025
EPS / Forecast
-0.12 / --
Revenue / Forecast
28.33M / --
EPS Revisions
Last 90 days

688221 Income Statement

FAQ

What Stock Exchange Does Frontier Biotechnologies Trade On?

Frontier Biotechnologies is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Frontier Biotechnologies?

The stock symbol for Frontier Biotechnologies is "688221."

What Is the Frontier Biotechnologies Market Cap?

As of today, Frontier Biotechnologies market cap is 8.06B.

What Is Frontier Biotechnologies's Earnings Per Share (TTM)?

The Frontier Biotechnologies EPS (TTM) is -0.51.

When Is the Next Frontier Biotechnologies Earnings Date?

Frontier Biotechnologies will release its next earnings report on 28 Oct 2025.

From a Technical Analysis Perspective, Is 688221 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Frontier Biotechnologies Stock Split?

Frontier Biotechnologies has split 0 times.

How Many Employees Does Frontier Biotechnologies Have?

Frontier Biotechnologies has 302 employees.

What is the current trading status of Frontier Biotechnologies (688221)?

As of 03 Aug 2025, Frontier Biotechnologies (688221) is trading at a price of 21.53, with a previous close of 21.47. The stock has fluctuated within a day range of 20.98 to 23.30, while its 52-week range spans from 4.48 to 24.67.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.